Pricing Log in Create free account
Friday 6 November 2026 Export XERS’s income statement to Excel — free account

Xeris Biopharma Holdings, Inc.

XERS Healthcare Drug Manufacturers Specialty & Generic

Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024.

Revenue
+44.2%
EPS
+1,479.0%
Free cash flow
+93.2%
Total debt
−13.6%

Quarter to September 2026, against a year earlier

15.16 2.08 +15.90%
Market cap
$2.4B
P/E
0.0×
Fwd P/E
−143×
Dividend yield
—
F-score
8/9
Altman Z
0.98
Beneish M
−2.58
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Xeris Biopharma Holdings, Inc. (XERS) Current ratio

Alert me on Current ratio

Xeris Biopharma Holdings, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.2×, down 0.0× from fiscal 2025 (2.2×). Over the past ten years it has ranged from 1.6× (fiscal 2023) to 13.1× (fiscal 2016); the current reading is higher than 40% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.5× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.2× 31.39%
FY2024 1.7× 1.69%
FY2023 1.6× (35.31%)
FY2022 2.5× 40.66%
FY2021 1.8× (66.57%)
FY2020 5.4× 68.63%
FY2019 3.2× (72.39%)
FY2018 11.6× 27.87%
FY2017 9.1× (30.95%)
FY2016 13.1× —

Quarterly newest first

Period Current ratio Change
Sep 2026 2.2× 48.41%
Jun 2026 1.4× (31.70%)
Mar 2026 2.1× (3.24%)
Dec 2025 2.2× 13.76%
31 more quarters

Against its own ten years

Low 1.6× High 13.1×
Ten-year median 2.9×
Current reading's percentile 40

Current ratio against peers

Company Current ratio
AMLX Amylyx Pharmaceuticals, Inc. compare 12.1×
RGC Regencell Bioscience Holdings Limited compare 10.8×
HCM HUTCHMED (China) Limited Sponsored ADR compare 5.6×
TRLV Trulieve Cannabis Corp. compare 5.5×
PBH Prestige Consumer Healthcare Inc. compare 2.9×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.7×
PRGO Perrigo Company plc compare 2.4×
XERS Xeris Biopharma Holdings, Inc. 2.2×
ALVO Alvotech compare 1.6×
Drug Manufacturers Specialty & Generic industry median 2.5×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on XERS